Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept in plaque psoriasis
NCT00111111Phase 3Completed
- Sponsor
- Amgen
- Modality
- Fc-Fusion Proteins
01
Overview
A Phase 3 trial of etanercept in plaque psoriasis, sponsored by Amgen. Status: completed.
02
Drugs
etanercept
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00111111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00111111.